Dupilumab Holds Up Over 52 Weeks in Prurigo Nodules
Dutch BioDay registry researchers report 52-week real-world effectiveness and safety of dupilumab in prurigo nodularis in JAAD, Volume 95, Issue 5, November 2026.
Topic
Bioday Registry
Topic
Topic
Topic
Dutch BioDay registry researchers report 52-week real-world effectiveness and safety of dupilumab in prurigo nodularis in JAAD, Volume 95, Issue 5, November 2026.